Skip to main content

Table 1 5'-aza-deoxycytidine induced re-activation of NK2-3 gene expression in ovarian cancer cell lines

From: DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage

cell line

dose 5'-aza-dC (uM)

fold increase over untreated control cells

ES2

2

1.3

ES2

10

7.2

OVCAR3

2

55

OVCAR3

10

359